Cache Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.43M Sell
1,235
-824
-40% -$972K 0.09% 67
2026
Q2
$2.47M Hold
2,059
– – 0.21% 47
2026
Q1
$1.89M Hold
2,059
– – 0.22% 34
2025
Q4
$2.21M Sell
2,059
-1,541
-43% -$1.47M 0.27% 30
2025
Q3
$2.75M Hold
3,600
– – 0.48% 24
2025
Q2
$2.81M Hold
3,600
– – 0.76% 28
2025
Q1
$2.97M Buy
3,600
+1,000
+38% +$832K 1.14% 17
2024
Q4
$2.01M Buy
+2,600
New +$2.15M 0.84% 26

Other funds holding LLY

Cache Advisors's LLY Position: Q3 2026 in Review

Cache Advisors reduced its Eli Lilly (LLY) stake by 40% in Q3 2026, selling an estimated $972K and leaving 1,235 shares worth $1.43M. The position accounts for 0.09% of the portfolio, ranked #67.

Cache Advisors first reported a position in LLY in Q4 2024 and has held it in 8 quarters since. The position peaked at $2.97M in Q1 2025. 1,260 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Cache Advisors held 1,235 shares of Eli Lilly worth $1.43M as of Q3 2026.
  • Cache Advisors sold 824 Eli Lilly shares in Q3 2026, an estimated $972K.
  • Eli Lilly made up 0.09% of Cache Advisors's portfolio in Q3 2026, its #67 holding.
  • Cache Advisors first reported a position in Eli Lilly in Q4 2024 and has held it in 8 quarters since.
  • Cache Advisors's Eli Lilly position peaked at $2.97M in Q1 2025.
  • 1,260 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Cache Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.